Dr Martin Everett | Head of Research
MerLion Pharmaceuticals

Martin Everett joined MerLion in 2005, initially as Head of Biological Sciences, becoming Head of Research in 2008. Before joining MerLion he worked at Glaxo SmithKline in the UK on anti-tubercular drug discovery and led a team performing automated high throughput screening of enzyme targets within the Molecular Screening department. Between 1993-96 he was a postdoctoral fellow in the Antibiotic Research Group at the University of Birmingham, investigating the molecular causes of antibiotic resistance in clinical and veterinary pathogens. He obtained a Bsc in Microbiology from University of Wales, College of Swansea, in 1987 and a PhD from University of Bristol in 1992.